Annex

United Kingdom

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry corresponding to prednisolone is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification
‘Prednisolone Prednisolone Bovine 4 μg/kg Muscle NO ENTRY Corticoids/Glucocorticoids’
4 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
6 μg/kg Milk
Equidae 4 μg/kg Muscle
8 μg/kg Fat
6 μg/kg Liver
15 μg/kg Kidney

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic classification
‘Prednisolone	Prednisolone	Bovine	4 μg/kg	Muscle	NO ENTRY	Corticoids/Glucocorticoids’
			4 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			6 μg/kg	Milk
		Equidae	4 μg/kg	Muscle
			8 μg/kg	Fat
			6 μg/kg	Liver
			15 μg/kg	Kidney